| Style | Citing Format |
|---|---|
| MLA | Nateghi A, et al.. "Epidemiology and Clinical Features of Respiratory Viruses in Hospitalized Iranian Children During the Covid-19 Pandemic." Immunity, Inflammation and Disease, vol. 13, no. 9, 2025, pp. -. |
| APA | Nateghi A, Hamrahjoo M, Yasaghi M, Ramzali M, Samadizadeh S, Fotouhi F, Salimi V, Shahkar L, Nakstad B, Tahamtan A (2025). Epidemiology and Clinical Features of Respiratory Viruses in Hospitalized Iranian Children During the Covid-19 Pandemic. Immunity, Inflammation and Disease, 13(9), -. |
| Chicago | Nateghi A, Hamrahjoo M, Yasaghi M, Ramzali M, Samadizadeh S, Fotouhi F, Salimi V, Shahkar L, Nakstad B, Tahamtan A. "Epidemiology and Clinical Features of Respiratory Viruses in Hospitalized Iranian Children During the Covid-19 Pandemic." Immunity, Inflammation and Disease 13, no. 9 (2025): -. |
| Harvard | Nateghi A et al. (2025) 'Epidemiology and Clinical Features of Respiratory Viruses in Hospitalized Iranian Children During the Covid-19 Pandemic', Immunity, Inflammation and Disease, 13(9), pp. -. |
| Vancouver | Nateghi A, Hamrahjoo M, Yasaghi M, Ramzali M, Samadizadeh S, Fotouhi F, et al.. Epidemiology and Clinical Features of Respiratory Viruses in Hospitalized Iranian Children During the Covid-19 Pandemic. Immunity, Inflammation and Disease. 2025;13(9):-. |
| BibTex | @article{ author = {Nateghi A and Hamrahjoo M and Yasaghi M and Ramzali M and Samadizadeh S and Fotouhi F and Salimi V and Shahkar L and Nakstad B and Tahamtan A}, title = {Epidemiology and Clinical Features of Respiratory Viruses in Hospitalized Iranian Children During the Covid-19 Pandemic}, journal = {Immunity, Inflammation and Disease}, volume = {13}, number = {9}, pages = {-}, year = {2025} } |
| RIS | TY - JOUR AU - Nateghi A AU - Hamrahjoo M AU - Yasaghi M AU - Ramzali M AU - Samadizadeh S AU - Fotouhi F AU - Salimi V AU - Shahkar L AU - Nakstad B AU - Tahamtan A TI - Epidemiology and Clinical Features of Respiratory Viruses in Hospitalized Iranian Children During the Covid-19 Pandemic JO - Immunity, Inflammation and Disease VL - 13 IS - 9 SP - EP - PY - 2025 ER - |